XHS ETF Analysis: S&P Health Care | NYSE

Healthcare Equity | NYSE, USA | Market Cap: 232m USD | 12M Return: 43.6% | US78464A5737 | Charts, Fundamentals & Technical Analysis

Health Insurance, Hospital Operators, Diagnostic Testing, Physician Networks
Total Rating 81
Safety 77
Buy Signal 0.89
Healthcare Equity
Category Rotation: +2.5
TER: 0.34%
AUM: 232M
Avg Turnover: 3.68M
Risk 3d forecast
Volatility20.4%
VaR 5th Pctl3.56%
VaR vs Median-3.08%
Reward TTM
Sharpe Ratio1.84
Rel. Str. IBD88.9
Rel. Str. Peer Group88.1 pctl
Character TTM
Beta0.430
Beta Downside0.313
Hurst Exponent0.474
Choppyness12.3%
Drawdowns 3y
Max DD14.47%
CAGR/Max DD1.48
CAGR/Mean DD5.89

Warnings

No concerns identified

Tailwinds

Rs Leader

Seasonality 11.8 years of data

Jan +2.0% 5
Feb -0.3% 2
Mar -1.4% 16
Apr +0.2% 5
May +1.5% 9
Jun +1.5% 18
Jul +2.1% 18
Aug -1.9% 34
Sep -2.0% 34
Oct -1.2% 36
Nov +3.6% 39
Dec +0.6% 11

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: XHS S&P Health Care

SPDR® S&P Health Care Services ETF (XHS) seeks to track the S&P Health Care Services Select Industry Index using a sampling strategy. It generally invests at least 80% of its assets in securities included in the index.

The index covers the health care services segment of the S&P Total Market Index. This sector includes businesses that deliver or manage health care services, such as care providers and managed-care companies.

Headlines to Watch Out For
  • Medicare reimbursement changes pressure provider revenue and margins
  • Aging population lifts demand for healthcare services
  • Wage inflation and staffing shortages constrain provider profitability
What is the price of XHS shares?

As of November 11, 2026, the stock is trading at USD 147.59 with a total of 32,823 shares traded. Over the past week, the price has changed by +4.03%, over one month by +7.54%, over three months by +8.00% and over the past year by +43.61%.

Current recommended Stop Loss: 141.60 (which is 4.1% or 2 ATR below the current price).

Is XHS a buy, sell or hold?

S&P Health Care has no consensus analysts rating.